Linical Co., Ltd.

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40008446

Informations générales

Localisation

Japan

Asia

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

12/06/2025

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon FY2034

Statut

Targets set

Classification

1.5°C

Année cible

FY2034

Progression vers l'objectif0%
2015 (année de référence)FY2034
Description complète des objectifs

Near-Term Targets: Linical Co., Ltd. commits to reduce absolute scope 2 GHG emissions 58.8% by FY2034 from a FY2023 base year. Linical Co., Ltd. also commits that 75% of its suppliers by emissions covering purchased goods and services and business travel will have science-based targets by FY2029.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

JP3974530002

Source : Science Based Targets initiative | Données publiques